New perspectives in diabetic neuropathy

SA Eid, AE Rumora, B Beirowski, DL Bennett, J Hur… - Neuron, 2023 - cell.com
Diabetes prevalence continues to climb with the aging population. Type 2 diabetes (T2D),
which constitutes most cases, is metabolically acquired. Diabetic peripheral neuropathy …

TFOS Lifestyle: impact of nutrition on the ocular surface

M Markoulli, S Ahmad, J Arcot, R Arita… - The ocular …, 2023 - Elsevier
Nutrients, required by human bodies to perform life-sustaining functions, are obtained from
the diet. They are broadly classified into macronutrients (carbohydrates, lipids, and proteins) …

[HTML][HTML] Prevention and management strategies for diabetic neuropathy

S Smith, P Normahani, T Lane… - Life, 2022 - mdpi.com
Diabetic neuropathy (DN) is a common complication of diabetes that is becoming an
increasing concern as the prevalence of diabetes rapidly rises. There are several types of …

Microvascular complications of obesity and diabetes—Role of bariatric surgery

B Bashir, Z Iqbal, S Adam, M Ferdousi… - Obesity …, 2023 - Wiley Online Library
Bariatric surgery in people with obesity can lead to long‐term remission of type 2 diabetes
mellitus (T2DM) and a reduction in the incidence of macrovascular complications. The …

Corneal confocal microscopy predicts the development of diabetic neuropathy: a longitudinal diagnostic multinational consortium study

BA Perkins, LE Lovblom, EJH Lewis, V Bril… - Diabetes …, 2021 - diabetesjournals.org
OBJECTIVE Corneal nerve fiber length (CNFL) has been shown in research studies to
identify diabetic peripheral neuropathy (DPN). In this longitudinal diagnostic study, we …

The global and regional burden of diabetic peripheral neuropathy

MG Savelieff, MA Elafros, V Viswanathan… - Nature Reviews …, 2024 - nature.com
Diabetic peripheral neuropathy (DPN) is length-dependent peripheral nerve damage arising
as a complication of type 1 or type 2 diabetes in up to 50% of patients. DPN poses a …

Severe hypertriglyceridaemia and chylomicronaemia syndrome—causes, clinical presentation, and therapeutic options

B Bashir, JH Ho, P Downie, P Hamilton, G Ferns… - Metabolites, 2023 - mdpi.com
We have reviewed the genetic basis of chylomicronaemia, the difference between
monogenic and polygenic hypertriglyceridaemia, its effects on pancreatic, cardiovascular …

Lipids and peripheral neuropathy

Z Iqbal, B Bashir, M Ferdousi, A Kalteniece… - Current Opinion in …, 2021 - journals.lww.com
Hyperlipidaemia, particularly hypertriglyceridemia, is associated with the development and
progression of neuropathy. Lipid modifying agents may represent a potential therapeutic …

[HTML][HTML] Corneal confocal microscopy: a biomarker for diabetic peripheral neuropathy

IN Petropoulos, G Ponirakis, M Ferdousi, S Azmi… - Clinical …, 2021 - Elsevier
Purpose Diagnosing early diabetic peripheral neuropathy remains a challenge due to
deficiencies in currently advocated end points. The cornea is densely innervated with small …

Prevalence and risk factors for diabetic peripheral neuropathy, neuropathic pain and foot ulceration in the Arabian Gulf region

G Ponirakis, T Elhadd, E Al Ozairi… - Journal of Diabetes …, 2022 - Wiley Online Library
Abstract Aims/Introduction This study determined the prevalence and risk factors for diabetic
peripheral neuropathy (DPN), painful DPN and diabetic foot ulceration (DFU) in patients with …